MyAverix Finance
US · Healthcare
Wuhan General Gr Chn (WUHN)
Drug Manufacturers - Specialty & Generic
Wuhan General Gr Chn (WUHN) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for WUHN
Wuhan General Gr Chn (WUHN) — FAQ
What is WUHN's P/E ratio?
The price-to-earnings (P/E) ratio for Wuhan General Gr Chn (WUHN) is 18.00 (data as of 2026-05-23).
Does Wuhan General Gr Chn pay a dividend?
Dividend yield is not available in the current snapshot for Wuhan General Gr Chn (WUHN). Check the MyAverix Finance app for the latest dividend data.
What sector is Wuhan General Gr Chn in?
Wuhan General Gr Chn (WUHN) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is WUHN listed on?
WUHN is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.